You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgen

Showing 26 - 50 of 2,303
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Atlanta (Genistein, Placebo)

Terminated
Has Results
  • Prostate Cancer
  • Atlanta, Georgia
    Emory University
Sep 7, 2022

Breast Cancer With or Without BRCA Mutation

Recruiting
  • Breast Cancer
  • Androgen receptor status and BRCA mutation
  • Varanasi, UP, India
    Banaras Hindu University
Jun 2, 2022

Physical Function During ARSI Treatment

Recruiting
  • Advanced Prostate Carcinoma
  • androgen receptor signaling inhibitors
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Nov 8, 2022

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Prostate Cancer Trial in Houston (Cabozantinib, Androgen Ablation Therapy)

Completed
Has Results
  • Prostate Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

Prostate Cancer Trial in Atlanta, Charleston (Opaganib, Abiraterone, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Atlanta, Georgia
  • +1 more
Dec 28, 2022

Prostate Cancer Trial in Miami (FTLEAD, Ultra-Short-Term Androgen Deprivation Therapy with Relugolix, HypoLEAD)

Not yet recruiting
  • Prostate Cancer
  • FTLEAD
  • +3 more
  • Miami, Florida
    University of Miami
Oct 26, 2023

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel Trial in Nanjing (Docetaxel injection, Triptorelin Pamoate for

Active, not recruiting
  • Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
  • Docetaxel injection
  • +2 more
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Dec 24, 2022

Prostate Cancer Trial in San Francisco (STAND-T platform, Survey Administration, Text Messages)

Recruiting
  • Prostate Cancer
  • STAND-T platform
  • +2 more
  • San Francisco, California
  • +1 more
Oct 26, 2022

Prostate Cancer, Insulin Resistance, Diabetes, Type 2 Trial in Buffalo (Pioglitazone 30 mg, Placebo)

Recruiting
  • Prostate Cancer
  • +3 more
  • Pioglitazone 30 mg
  • Placebo
  • Buffalo, New York
    Diabetes and Endocrinology Research Center of WNY
Oct 26, 2022

Prostate Cancer Trial in Multiple Locations (Darolutamide 600 mg twice daily, Placebo 600 mg twice daily, Androgen deprivation

Recruiting
  • Prostate Cancer
  • Darolutamide 600 mg twice daily
  • +2 more
  • Multiple Locations, China
    Many Locations
Aug 2, 2022

Prostate Cancer Trial in Sherbrooke (Androgen blockade + radiation therapy)

Active, not recruiting
  • Prostate Cancer
  • Androgen blockade + radiation therapy
  • Sherbrooke, Quebec, Canada
    Centre de Recherche Clinique du CHUS
May 20, 2022

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +3 more
Jan 17, 2023

Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • San Francisco, California
    University of California San Francisco
Sep 20, 2022

Hormonal Associations in Male Patients With Psoriasis Vulgaris

Not yet recruiting
  • Psoriasis Vulgaris
  • Morning blood sample and skin punch biopsy of 4 mm diameter.
  • (no location specified)
Feb 3, 2023

Prostate Cancer Trial in Birmingham (Abemaciclib 150 MG by mouth twice daily, Androgen deprivation therapy (ADT), Radiation

Recruiting
  • Prostate Cancer
  • Abemaciclib 150 MG by mouth twice daily
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham (UAB)
Mar 18, 2022

Androgen Deprivation-related Sarcopenia

Recruiting
  • Metastatic Prostate Cancer
  • Androgen Deprivation Therapy
  • GnRH agonist
  • Seattle, Washington
    Veterans Affairs Puget Sound Health Care System
Mar 16, 2022

REFUEL PCOS Study 1

Not yet recruiting
  • Polycystic Ovary Syndrome
    • Dublin, Ireland
      Royal Collage Of Surgeons
    Jul 25, 2023

    Recurrent Prostate Cancer Trial in Salisbury, Winston-Salem (MGE, Placebo, ADT)

    Recruiting
    • Recurrent Prostate Cancer
    • Salisbury, North Carolina
    • +1 more
    Nov 2, 2022

    Castrate Resistant Prostate Cancer Trial in Chicago, Indianapolis, Hershey (Ipatasertib, Darolutamide, Androgen Deprivation

    Recruiting
    • Castrate Resistant Prostate Cancer
    • Chicago, Illinois
    • +2 more
    Jul 19, 2022

    Strength, Aging, and Memory in Prostate Cancer

    Active, not recruiting
    • Prostate Neoplasm
    • Prostate Cancer
    • Androgen deprivation therapy
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Jul 13, 2022

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Jan 23, 2023

    Metastatic Castrate-sensitive Prostate Cancer Trial in Germany, United States (Apalutamide, Androgen-deprivation Therapy (ADT))

    Not yet recruiting
    • Metastatic Castrate-sensitive Prostate Cancer
    • Lakewood, Colorado
    • +5 more
    May 23, 2023